27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

4. Pathway engineering: Selection of hosts , genetic engineering, metabolic<br />

pathway engineering, homogeneous morphology<br />

5. Strain development and improvement: Promoter selection, manipulation<br />

of operons, yield improvement<br />

6. Large-scale production: Process development, lab fermentation, scale-up,<br />

recovery, formulation<br />

PRODUCTS ON MARKET: Enzymes for industrial use (technical enzymes, comprising detergent<br />

enzymes, those sold to the ethanol industry, and and other technical<br />

enzymes; food enzymes; and feed enzymes)<br />

Microorganisms for industrial use, such as cleaning, wastewater treatment,<br />

aquaculture and biological plant care<br />

Biopolymers and pharmaceutical proteins<br />

More than 700 different products total<br />

Novozymes Inc.<br />

1445 Drew Avenue<br />

Davis CA 95616, US<br />

Phone: (530) 757-8100; Fax: (530) 758-0317<br />

Web: www.novozymesbiotech.com<br />

E-mail: info@novozymes.com<br />

KEY PERSONNEL: Glenn E. Nedwin, Ph.D.; President<br />

Randy M. Berka, Ph.D.; Research Fellow, Core Technologies<br />

Debbie Yaver, Ph.D.; Senior Research Manager<br />

Joel Cherry, Ph.D.; Director, Bioenergy<br />

Alan Sloma, Ph.D.; Director, Molecular Biology<br />

Stephen H. Brown, Ph.D.; Research Manager, Microbial Physiology<br />

Rasmus Thaisen; Finance Manager<br />

Marta L. Hillesheim; Director, People and Organization<br />

EMPLOYEES: 75 employees, 25 Ph.D.s<br />

HISTORY: Founded in January 1992<br />

Member--Biotechnology Industry Organization<br />

Changed name from Novo Nordisk Biotech Inc. (11/00)<br />

Changed name from Novozymes Biotech Inc.<br />

FACILITIES: 38,000 sq. ft. facility<br />

STOCK-FINANCIAL HISTORY: Privately held<br />

Parent company, Novozymes A/S, traded on Copenhagen stock market<br />

SUBSIDIARY OF: Novozymes A/S<br />

BUSINESS STRATEGY: Focus is on industrial biotechnology R&D and biosolutions: pharma, agribiotech<br />

and biochemical<br />

Operates as the U.S. research arm of Novozymes A/S<br />

Pursue endeavors and collaborations involving novel enzymes, novel<br />

enzyme applications and novel production technology<br />

RESEARCH & DEVELOPMENT: Cloning, expression, mutagenesis, and characterization of industrial<br />

enzymes<br />

Develop novel high-level expression systems<br />

Functional genomics<br />

Detergents, textiles, starch, food, baking, wine, juice, beer, pulp & paper,<br />

fats, feed and personal care<br />

Low-allergenic protein technology<br />

Anti-microbial compounds<br />

Biopolymers, e.g., hyaluronic acid<br />

Copyright ©2006 AHC Media ® 287

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!